Screener
LABD vs LABU
Direxion Daily S&P Biotech Bear 3X Shares vs Direxion Daily S&P Biotech Bull 3X Shares
Key differences
- LABU costs 0.11% less per year.
- LABU is significantly larger than LABD — larger funds tend to be more liquid and less likely to close.
- LABD follows a inverse strategy; LABU uses leveraged.
- Over the last 3 years, LABU has delivered higher annualized returns.
Side-by-side comparison
| LABD | LABU | |
|---|---|---|
| Annual cost (TER) | 1.07% | 0.96% |
| Fund size (AUM) | $69M | $528M |
| Since | 2015 | 2015 |
| Dividend yield | 6.38% | 0.69% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | inverse | leveraged |
| CAGR 1Y | -82.9% | +246.3% |
| CAGR 3Y | -50.8% | +10.2% |
| CAGR 5Y | -42.0% | -32.0% |
| Sharpe 3Y | -0.52 | 0.48 |
| Volatility 1Y | 74.72% | 75.02% |
| Max drawdown | -99.98% | -98.96% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to LABD and LABU
Explore further